5Bosch J.Vascular deterioration in cirrhosis:the big picture[J].Journal of Clinical Gastroenterology,2007,41:S247-S253. 被引量:1
6Ames RS,Sarau HM,Chambers JK,et al.Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphanreceptor GPR14[J].Nature,1999,401:282-286. 被引量:1
7Trebicka J,Leifeld L,Hennenberg M,et al.Hemodynamic effects of urotensinⅡ and its specific receptor antagonist palosuran in cirrhotic rats[J].Hepatology,2008,47(4):1264-1276. 被引量:1
8Gatta A,Sacerdoti D,Bolognesi M,et al.Portal hypertension:state of the art[J].Ital J Gastroenterol Hepatol,1999,31(4):326-345. 被引量:1
9Kemp W,Krum H,Colman J,et al.UrotensinⅡ:a novel vasoactive mediator linked to chronic liver disease and portal hypertension[J].Liver Int,2007,27(9):1232-1239. 被引量:1
10Heller J,Schepke M,Neef M,et al.Increased urotensin Ⅱ plasma levels in patients with cirrhosis and portal hypertension[J].Journal of hepatology,2002,37(6):767-772. 被引量:1